Salary: Grade 7: £31,604 - £38,833 p.a.
This is a unique opportunity for a motivated and highly skilled Postdoctoral Scientist to join the research group of Professor Adam Mead at the MRC Weatherall Institute of Molecular Medicine (WIMM) to use a number of state-of-the-art molecular and cellular techniques to undertake a project focused on identification and therapeutic targeting of abnormal bone marrow stromal cells in myelofibrosis, a severe myeloproliferative neoplasm.
The position is available fixed-term until 31/10/2021 and is funded by the Kay Kendall Leukaemia Fund.
The Mead laboratory is focused on studying normal and malignant haematopoiesis, with a focus on single-cell approaches. This exciting project, at the forefront of its field, will employ combined single-cell targeted mutational analysis and RNA-sequencing with novel in vivo models to determine the molecular mechanism driving the destructive bone marrow fibrosis in myelofibrosis.
You will hold a PhD (or near to completion), together with relevant experience in haematopoiesis and/or single-cell transcriptomics. Experience in molecular biology, FACS analysis and cell culture techniques are desirable. A strong publication record in peer-reviewed journals is necessary, as well as the ability to work independently and as part of a team. You will have excellent communication and organisational skills, with the ability to manage and independently drive, innovate and complete your own research and associated activities.
Applications for this vacancy are to be made online. You will be required to upload a CV and supporting statement as part of your online application.
The closing date for this position is 12.00 noon on Monday 9 July 2018.